📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer A Life-Table Model (2018)

First Author: Pashayan N

Attributed to: FUTURE TARGETED HEALTHCARE MANUFACTURING HUB funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jamaoncol.2018.1901

PubMed Identifier: 29978189

Publication URI: http://europepmc.org/abstract/MED/29978189

Type: Journal Article/Review

Parent Publication: JAMA Oncology

Issue: 11

ISSN: 2374-2437